Currency Fluctuations
Weaker USD impacts revenue and profitability.
- Materiality
- high
Boule Diagnostics
Boule Diagnostics AB is a global diagnostics company specializing in near-patient, decentralized blood diagnostics. The company is unique in the diagnostics market for conducting its own development, manufacturing, and marketing of instruments and consumables for blood diagnostics. Boule primarily serves hospitals, clinics, laboratories, and other diagnostics companies, offering complete systems for hematology in both human and veterinary areas. With strong positions in emerging markets like Asia, Boule has been expanding its presence in the fast-growing veterinary market.
200
1.09
0.74
| % | |
|---|---|
| Human Diagnostics | 55% Includes hematology analyzers and consumables for human blood diagnostics. |
| Veterinary Diagnostics | 20% Instruments and consumables for veterinary blood diagnostics. |
| OEM Solutions | 15% Contract development and manufacturing of reagents and blood controls. |
| Consumables | 10% Includes calibration and quality control products for diagnostics. |
Boule Diagnostics serves a diverse range of customers, including hospitals, clinics, laboratories, and other...
- Hospitals and Clinicsprimary
Purchase hematology analyzers and consumables for patient diagnostics.
- Veterinary Clinicssecondary
Use veterinary diagnostics instruments for animal health.
- OEM Customersemerging
Contract for reagents and blood controls manufacturing.
Boule Diagnostics operates globally with subsidiaries in Sweden, the United States, Mexico, and Russia...
- •Global operations with subsidiaries in Sweden, USA, Mexico, and Russia
- •Strong presence in emerging markets, especially Asia
- •Products distributed in over 100 countries
- •Local sales and service teams support global distribution
- •Geographic diversity helps mitigate regional economic risks
Boule Diagnostics is focused on expanding its installed base of instruments and enhancing its multi-brand strategy...
01
Expand Installed Basemedium-term
To increase market penetration and recurring revenue from consumables.
02
Strategic Partnershipslong-term
To accelerate access to new technologies and broaden product portfolio.
03
Focus on OEM Marketmedium-term
To capture growth opportunities in reagents and blood controls.
Boule Diagnostics faces several risks, including currency fluctuations, particularly the impact of a weaker US dollar...
Regulatory Changes
Could alter market access and compliance costs.
- Materiality
- medium
Delayed Payments
Affects cash flow and delivery schedules.
- Materiality
- medium
Revenue Recognition
Capitalized Development Expenditure
IFRS 16
Lease Accounting (IFRS 16)
Getinge
GETI-B.ST · Health Care
Getinge AB is a global provider of products and solutions for healthcare and life sciences, focusing on intensive care, cardiovascular procedures, operating…
Thule Group
THULE.ST · Consumer Discretionary
Thule Group is a global company specializing in sports and outdoor products designed to simplify active lifestyles.
VOLITIONRX LTD
VNRX · In Vitro & In Vivo Diagnostic Substances
VolitionRx Ltd is a U.S.-based epigenetics diagnostics company developing blood-based tests that use nucleosomes and related biomarkers to detect and monitor disease.
Fulgent Genetics, Inc.
FLGT · Services-Medical Laboratories
IDEXX LABORATORIES INC /DE
IDXX · In Vitro & In Vivo Diagnostic Substances
IDEXX Laboratories develops and sells diagnostic products and services for veterinarians, livestock producers, water testing customers, and selected human point-of-care uses.
QuidelOrtho Corp
QDEL · In Vitro & In Vivo Diagnostic Substances
QuidelOrtho Corp develops and markets diagnostic testing products used to detect, monitor, and help manage disease across clinical and decentralized care settings.
: 11/08/2026